The Improved Experience You’ve Been Waiting For! Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach. Explore Now

PRAC:XETRA Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C)

EUR 19.25 0.04 ( 0.216056)
Icon

Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C) (PRAC:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
Target Add to Watchlist
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 19.25

+0.04 (+0.22)%

EUR 1.21B

0.04M

EUR -1.00

N/A
Icon

PRAC:XETRA

Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C) (EUR)
ETF | XETRA
EUR 19.25
0.04 ( 0.216056)
Watchlist

Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C) (PRAC:XETRA) Stock Forecast

EUR -1.00

Based on the Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C) stock forecast from 0 analysts, the average analyst target price for Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C) is not available over the next 12 months. Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C) is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C)’s stock price was EUR 19.25. Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (C)’s stock price has changed by +0.57% over the past week, +0.84% over the past month and +8.42% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
Stock Target Advisor

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like